Table 2.
Structure and activity of the synthesized thiazolyl and benzothiazolyl inhibitors
| Entry | Compound | Structurea | Kib (µM) |
|---|---|---|---|
| 1 | 8b | ![]() |
21.0 ± 4.3 |
| 2 | 14a | ![]() |
478 ± 193 |
| 3 | 14b | ![]() |
112 ± 34 |
| 4 | 21 | ![]() |
2.20 ± 0.8 |
| 5 | 26 | ![]() |
45.2 ± 7.8 |
| 6 | 14c | ![]() |
462 ± 145 |
| 7 | 14d | ![]() |
614 ± 139 |
| 8 | 14e | ![]() |
49.3 ± 10 |
| 9 | 14f | ![]() |
159 ± 25 |
Cbz, benzyloxycarbonyl.
Ki, inhibition constant against SARS-CoV 3CLpro.








